Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03390504 |
|---|---|
| Brief Title: | A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations (THOR) |
| First Submitted : | December 20, 2017 |
| First Submitted that Met QC Criteria : | January 3, 2018 |
| First Posted : | January 4, 2018 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 25, 2024 |